Literature DB >> 18698138

Effects of vitamins C and E on the outcome after acute myocardial infarction in diabetics: a retrospective, hypothesis-generating analysis from the MIVIT study.

Tomasz Jaxa-Chamiec1, Bronislaw Bednarz, Krystyna Herbaczynska-Cedro, Pawel Maciejewski, Leszek Ceremuzynski.   

Abstract

BACKGROUND: There is significant evidence that reactive oxygen species play an important role in endothelial dysfunction, ischemia/reperfusion injury as well as in the pathogenesis of diabetes mellitus (DM). It is also known that vitamins C and E have substantial antioxidant properties. However, clinical evidence concerning this topic is insufficient so far. The aim of the present study was to determine if the administration of vitamins C and E influences the outcome in diabetic patients with acute myocardial infarction (AMI).
METHODS: Among 800 patients with AMI included in the MIVIT (Myocardial Infarction and Vitamins) study, 122 patients (15%) had confirmed DM. A retrospective analysis of the influence of vitamins C and E on 30-day cardiac mortality in patients with or without DM was performed.
RESULTS: There was a significant reduction in 30-day cardiac mortality in diabetic patients treated with antioxidant vitamins C and E [5 (8%) vs. 14 (22%); OR 0.32, 95% CI 0.11-0.93; p = 0.036]. Such an effect has not been observed in patients without DM [19 (6%) vs. 19 (6%); OR 0.97, 95% CI 0.51-1.85; p = 0.94].
CONCLUSION: The results suggest that early administration of antioxidant vitamins C and E in patients with AMI and concomitant DM reduces cardiac mortality. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698138     DOI: 10.1159/000151239

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  11 in total

1.  Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase.

Authors:  Stefano Toldo; Mariarosaria Boccellino; Barbara Rinaldi; Ignacio M Seropian; Eleonora Mezzaroma; Anna Severino; Lucio Quagliuolo; Benjamin W Van Tassell; Raffaele Marfella; Giuseppe Paolisso; Francesco Rossi; Ramesh Natarajan; Norbert Voelkel; Antonio Abbate; Filippo Crea; Alfonso Baldi
Journal:  Mol Med       Date:  2011-05-31       Impact factor: 6.354

Review 2.  NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury.

Authors:  Pamela W M Kleikers; K Wingler; J J R Hermans; I Diebold; S Altenhöfer; K A Radermacher; B Janssen; A Görlach; H H H W Schmidt
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

Review 3.  Redox signalling and cardioprotection: translatability and mechanism.

Authors:  P Pagliaro; C Penna
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

4.  Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system.

Authors:  Ramón Rodrigo
Journal:  Front Physiol       Date:  2012-04-12       Impact factor: 4.566

5.  Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure.

Authors:  Cinzia Perrino; Gabriele G Schiattarella; Anna Sannino; Gianluigi Pironti; Maria Piera Petretta; Alessandro Cannavo; Giuseppe Gargiulo; Federica Ilardi; Fabio Magliulo; Anna Franzone; Giuseppe Carotenuto; Federica Serino; Giovanna G Altobelli; Vincenzo Cimini; Alberto Cuocolo; Assunta Lombardi; Fernando Goglia; Ciro Indolfi; Bruno Trimarco; Giovanni Esposito
Journal:  J Am Heart Assoc       Date:  2013-05-20       Impact factor: 5.501

Review 6.  Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarction.

Authors:  Ramón Rodrigo; Matías Libuy; Felipe Feliú; Daniel Hasson
Journal:  Biomed Res Int       Date:  2013-07-14       Impact factor: 3.411

7.  The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial.

Authors:  Ramón Rodrigo; Daniel Hasson; Juan C Prieto; Gastón Dussaillant; Cristóbal Ramos; Lucio León; Javier Gárate; Nicolás Valls; Juan G Gormaz
Journal:  Trials       Date:  2014-05-29       Impact factor: 2.279

Review 8.  Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning.

Authors:  Theodore Kalogeris; Yimin Bao; Ronald J Korthuis
Journal:  Redox Biol       Date:  2014-06-02       Impact factor: 11.799

Review 9.  The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies.

Authors:  Danina M Muntean; Adrian Sturza; Maria D Dănilă; Claudia Borza; Oana M Duicu; Cristian Mornoș
Journal:  Oxid Med Cell Longev       Date:  2016-04-21       Impact factor: 6.543

Review 10.  Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases.

Authors:  Feng He; Li Zuo
Journal:  Int J Mol Sci       Date:  2015-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.